IPOPLUS

Medisure Diagnostics

Open

Mainboard IPO · NSE, BSE · Healthcare

Price Band

₹410 – ₹432

Lot Size

34 shares

Issue Size

₹890 Cr

GMP (Grey Market Premium)

₹41 (9.5%)

About Medisure Diagnostics

Medisure Diagnostics operates a pan-India network of 420 diagnostic labs and 3,100 collection centres with a focus on tier-2 and tier-3 cities.

Issue Details
IPO Open Date9 Jun 2026
IPO Close Date11 Jun 2026
Basis of Allotment12 Jun 2026
Refunds Initiation15 Jun 2026
Listing Date16 Jun 2026
Face Value₹5
Fresh Issue₹590 Cr
Offer for Sale₹300 Cr
Minimum Investment (Retail)₹14,688
RegistrarKFin Technologies
Lead ManagersAxis Capital, JM Financial
Strengths
  • Second largest lab chain in North India
  • B2C revenue share of 71%
  • Strong EBITDA margins of 26%
Risks
  • Pricing pressure from aggregators
  • Regulatory changes in diagnostics
  • Competition from hospital chains
Subscription Status

Updated 9 Jun 2026, 8:21 pm

QIB3.8x
NII (HNI)9.6x
Retail4.2x
Total5.1x
Grey Market Premium

Updated 9 Jun 2026, 8:21 pm

₹41

Estimated listing: ₹473 (9.5% over upper band)

GMP is unofficial and indicative only. It is not a reliable predictor of listing price.